Public Company News

LG Energy Solution to Invest in Promising U.S. Lithium Metal Battery Technology Startup, Solidifying Leadership in Next-Generation Battery Technology

* LG Energy Solution announces equity investment in Sion Power, an Arizona -based startup that holds core patents for lithium metal battery technologies * The latest investment is part of company's dedication to open innovation, joining efforts with competent partners to tackle technological ch...

2024-01-25 07:00 2379

TuanChe Announces Plan to Implement ADS Ratio Change

BEIJING, Jan. 24, 2024 /PRNewswire/ — TuanChe Limited ("TuanChe" or the "Company") (NASDAQ: TC), a leading integrated automotive marketplace inChina, today announced that it plans to change the ratio of its American Depositary Shares ("ADSs") to Class A ordinary shares (the "ADS Ratio") from the ...

2024-01-24 23:50 5210

Caravelle's Chairman of the Board and CEO, Dr. Guohua Zhang, invited to Davos Summit 2024

--Milestone Initiative on Ocean Carbon Neutral Sustainability with Fortune 500 CEOs and ESG Leaders SINGAPORE, Jan. 24, 2024 /PRNewswire/ -- Dr Guohua Zhang, Chairman and CEO of Caravelle International Group (Nasdaq: CACO) , the world's leading ocean carbon neutral technology company, was invite...

2024-01-24 23:30 2522

RoboSense Joins Mcity to Help Drive the Future of Mobility

DETROIT, Jan. 24, 2024 /PRNewswire/ -- RoboSense (2498.HK), a leading innovator in LiDAR technology, today announced its membership inMcity , a public-private mobility research center led by theUniversity of Michigan.

2024-01-24 22:00 2419

Positive Xanamem® human PET study published in the Journal of Alzheimer's Disease demonstrating robust CNS[1] target enzyme occupancy

The study confirms that Xanamem is a brain-penetrant inhibitor of the tissue cortisol synthesis enzyme, 11β-HSD1, with high levels of target occupancy at doses as low as 5 mg SYDNEY, Jan. 24, 2024 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) announces that its human Positron Emission Tom...

2024-01-24 21:30 2356

Genome & Company Announces Positive Topline Results from Phase 2 Clinical Trial of Combination of GEN-001 and Bavencio® for the Treatment of Gastric Cancer Poster presented at ASCO GI

* Results showed partial response being confirmed in 7 out of 42 patients * Partial response was observed in 3 out of 8 patients who were previously treated by immunotherapy SEOUL, South Korea, Jan. 24, 2024 /PRNewswire/ -- Genome & Company (KOSDAQ: 314130), a clinical stage biotech leading in...

2024-01-24 21:00 2230

LG Innotek accelerating its entry into autonomous driving and XR markets

* Investing in a Taiwanese lens manufacturing corporation to enhance business competitiveness and supply chain. * Entered into a strategic partnership to cooperate in the area of optical components. * CEO Moon Hyuk-soo, "We will provide differentiated customer values with our overwhelming t...

2024-01-24 21:00 2402

Vipshop Releases the Carbon Reduction Goals and Action Report

- Outlining its Roadmap for Achieving Carbon Neutrality and Promoting Green Consumption GUANGZHOU, China, Jan. 24, 2024 /PRNewswire/ -- Vipshop, a leading online discount retailer for brands inChina ("Vipshop" or the "Company") recently released its Carbon Reduction Goals and Action Report (the ...

2024-01-24 20:00 2609

New Oriental Announces Results for the Second Fiscal Quarter Ended November 30, 2023

BEIJING, Jan. 24, 2024 /PRNewswire/ -- New Oriental Education & Technology Group Inc. (the "Company" or "New Oriental") (NYSE: EDU/ 9901.SEHK), a provider of private educational services inChina, today announced its unaudited financial results for the second fiscal quarter endedNovember 30, 2023,...

2024-01-24 19:42 4116

Harbour BioMed Announces IND Clearance for HBM9027 in the U.S.

CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Jan. 23, 2024 /PRNewswire/ -- Harbour BioMed (the "Company", HKEX: 02142) announced that the Company has been granted the clearance of Investigational New Drug (IND) from the Food and Drug Administration (FDA) ofthe United States to init...

2024-01-24 12:40 2387

WuXi XDC and Celltrion Sign MOU for Integrated Services for Antibody-Drug Conjugates (ADCs)

SHANGHAI and INCHEON, South Korea, Jan. 23, 2024 /PRNewswire/ -- WuXi XDC(2268.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO) focused on ADC and the other types of bioconjugate market, and Celltrion, Inc. (068270.KS), a leading global biopharmaceutical...

2024-01-24 11:37 2187

/DISREGARD RELEASE: Visionary Education Technology Holdings Group Inc./

We are advised by Visionary Education Technology Holdings Group Inc. that journalists and other readers should disregard the news release, Visionary Education Group Established a MOU withAlgoma University, issued 18-Jan-2024 over PR Newswire. ...

2024-01-24 11:37 7029

PharmAbcine Announces First Patient Dosed in Phase 1a/b Clinical Trial of PMC-309 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced or Metastatic Solid Tumors

* Initiation of Phase 1a/b clinical trial exploring MTD, RP2D, safety and tolerability of PMC-309 monotherapy and combination therapy with KEYTRUDA® * The clinical trial aims to enroll a total of 67 patients across four institutions inAustralia DAEJEON, South Korea, Jan. 23, 2024 /PRNewswire/ ...

2024-01-24 10:01 2061

JVSPAC Acquisition Corp. Announces Closing of $57.5 Million Initial Public Offering, Including Full Exercise of Underwriter's Over-Allotment Option

HONG KONG, Jan. 23, 2024 /PRNewswire/ -- JVSPAC Acquisition Corp. (NASDAQ:JVSAU) (the "Company"), a newly incorporated blank check company incorporated as aBritish Virgin Islands exempted company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reo...

2024-01-24 07:45 3642

Amcor to report Half Year 2024 results

ZURICH, Jan. 23, 2024 /PRNewswire/ -- Amcor plc (NYSE: AMCR; ASX: AMC) will announce its Half Year 2024 results for the six months ended31 December 2023 after the US market closes on Tuesday6 February 2024.   A conference call and webcast to discuss the results will be held at 5.30pm US Eastern ...

2024-01-24 06:59 3829

Mingzhu Receives Nasdaq Minimum Bid Price Requirement Extension

SHENZHEN, China, Jan. 23, 2024 /PRNewswire/ -- MingZhu Logistics Holdings Limited ("MingZhu" or the "Company") (NASDAQ: YGMZ), an elite provider of logistics and transportation services to businesses, today announced that on January 23, 2024, it received notification from The Nasdaq Stock Market L...

2024-01-24 05:00 2129

Coway Expands Cutting-Edge Air Purifier Product Line With Launch of Affordable, Cylindrical Model for Small Spaces: The Airmega 100

First Airmega With 360° Air Intake Turns Cozy Areas Into Wellness Sanctuaries With Robust, 3-Stage, HEPA Air Filtration System LOS ANGELES, Jan. 23, 2024 /PRNewswire/ -- Coway , a leading wellness tech company, today launched theAirmega 100

2024-01-24 02:00 3021

Datasea Pre-Announces First Half 2024 Revenue of $18.2 Million, a 1,037.5% Year-Over-Year Increase

BEIJING, Jan. 23, 2024 /PRNewswire/ -- Datasea Inc., (NASDAQ: DTSS) ("Datasea" or the "Company"), aNevada incorporated digital technology corporation engaged in converging and innovative business segments for intelligent acoustics and 5G messaging technology inChina pre-announced that its revenue...

2024-01-23 22:35 3927

Goodman's digital infrastructure offering powers ahead with data centre expansion in Asia

Key points: * Commenced infrastructure works for an available 1,000 MW of power at a new data centre campus in Tsukuba City,Greater Tokyo, Japan * Entered into a Heads of Agreement with a customer to lease the first 50 MW data centre to be developed at Goodman's new Tsukuba campus * ...

2024-01-23 22:00 3736

Akeso Presented Promising Results of Cadonilimab and Lenvatinib in Combination with TACE in uHCC at 2024 ASCO GI

HONG KONG, Jan. 23, 2024 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso," "we," or the "Company") today announced that the Company presented the promising phase II results of cadonilimab (a tetravalent PD-1/CTLA-4 bispecific antibody) and Lenvatinib (Len) combined with TACE for the treatment of mi...

2024-01-23 21:00 3852
1 ... 308309310311312313314 ... 773